Psoralen and Isopsoralen from Psoralea corylifolia Suppress NSCLC by Dual Mechanisms: STAT3 Inhibition and ROS

Liwei Bi1,2,3, Guangyi Chen1, Wanfen Liu1

  • 1Department of Pharmacy, Xiamen Medical College, Xiamen 361023, China.

PubMed

Insights

This study identifies psoralen and isopsoralen from traditional Chinese medicine as novel inhibitors of signal transducer and activator of transcription 3 (STAT3) for treating non-small cell lung carcinoma (NSCLC). These compounds combat NSCLC by suppressing STAT3 and modulating reactive oxygen species (ROS).

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology and Toxicology
  • Natural Product Chemistry

Background:

  • Non-small cell lung carcinoma (NSCLC) progression is linked to activated signal transducer and activator of transcription 3 (STAT3).
  • Traditional Chinese medicine offers potential sources for novel anti-cancer compounds.
  • Understanding STAT3's role in NSCLC necessitates identifying targeted natural products.

Purpose of the Study:

  • To develop a STAT3-targeting recognition system using surface plasmon resonance (SPR).
  • To identify natural STAT3 inhibitors from Psoralea corylifolia.
  • To evaluate the anti-NSCLC activities and reactive oxygen species (ROS) regulatory effects of identified compounds.

Main Methods:

  • Utilized SPR biosensors for screening and affinity determination of STAT3-binding compounds.
  • Employed molecular docking to analyze STAT3 SH2 domain interactions.
  • Assessed anti-proliferative and anti-migratory effects in A549 cells; evaluated antioxidant capacity and intracellular ROS levels in HUVECs and A549 cells.

Main Results:

  • Psoralen and isopsoralen were identified as STAT3 binders with specific affinities.
  • Both compounds inhibited NSCLC cell proliferation and migration.
  • Psoralen and isopsoralen exhibited antioxidant activity and modulated ROS levels differently in normal and cancer cells.

Conclusions:

  • Psoralen and isopsoralen are novel dual-function STAT3 inhibitors with anti-NSCLC potential.
  • Their efficacy stems from combined STAT3 suppression and context-dependent ROS modulation.
  • SPR technology is effective for screening bioactive natural products targeting specific proteins like STAT3.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K